2002
DOI: 10.1001/archderm.138.3.370
|View full text |Cite
|
Sign up to set email alerts
|

The First International Consensus on Mucous Membrane Pemphigoid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
299
0
9

Year Published

2002
2002
2017
2017

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 648 publications
(308 citation statements)
references
References 88 publications
0
299
0
9
Order By: Relevance
“…24% of patients with MMP have skin involvement, and 4% have esophageal involvement [5]. Scarring is one of the distinguishing features between MMP and BP as BP bullae do not leave scars, whereas MMP does [6]. In this paper we report a case of esophageal BP including an esophageal stricture.…”
Section: Introductionmentioning
confidence: 83%
See 2 more Smart Citations
“…24% of patients with MMP have skin involvement, and 4% have esophageal involvement [5]. Scarring is one of the distinguishing features between MMP and BP as BP bullae do not leave scars, whereas MMP does [6]. In this paper we report a case of esophageal BP including an esophageal stricture.…”
Section: Introductionmentioning
confidence: 83%
“…MMP usually involves oral mucosal involvement and causes scarring. Antigens identified in MMP include BP180, BP230, Laminin 5/6, Type VII collagen, and Integrin 4 subunit [6], whereas BP involves BP180 and BP230. It is important to differentiate esophageal BP from MMP as the approach to treatment can differ.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is characterised by bullous eruptions and ulceration, particularly of the oral mucosa and conjunctiva. 11 Eighty percent of the affected patients have oral lesions in the form of shallow ulcerations and a characteristic form of gingivitis known as desquamative gingivitis (see Figure 7). Seventy percent may have conjunctival lesions, 25% have genital lesions, and 20% have skin lesions.…”
Section: Diagnosismentioning
confidence: 99%
“…Management of gingival lesions of vesicobullous autoimmune diseases is one the main challenges to oral medicine, primarily because of their chronic nature. [1][2][3] Treatment of these lesions usually requires topical corticosteroids, or other anti-inflammatory drugs. Systemic therapy is required in most severe lesions, especially in pemphigus.…”
mentioning
confidence: 99%